Supernus Pharmaceuticals Inc (SUPN)
$41.92 +0.19% Close Oct 30, 2026 Live
Supernus Pharmaceuticals stock today
Supernus Pharmaceuticals closed at $41.92 on October 30, 2026, up 0.19% on the day. Over the past year it returned -25.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.43 billion.
$40.00$50.00
NovJan 2026MarMayJulSep
| Period | SUPN | S&P 500 (SPY) |
|---|---|---|
| 1 month | -2.6% | -0.9% |
| 3 months | -8.1% | +2.1% |
| Year to date | -15.7% | +11.7% |
| 1 year | -25.8% | +12.4% |
| 3 years | +77.5% | +88.5% |
| 5 years | +40.4% | +76.0% |
Key statistics
- Market value
- $2.43B
- Forward P/E
- 10.9
- Price / sales
- 2.9
- 52-week range
- $37.88 to $57.00
About Supernus Pharmaceuticals
Supernus Pharmaceuticals develops and commercializes pharmaceutical products for neurological and psychiatric disorders.
Sector: Health Care
More on Supernus Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +9% in the year to Dec 2025
- Valuation: P/E history and peers
- Returns: what $1,000 became$1,000 ten years ago is $2,035 today
No forecast, no recommendation. This page describes Supernus Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.